Arkolith/Insider Trading/APGE/Form 4

Dambkowski Carl

Chief Medical OfficerApogee Therapeutics, Inc. (APGE) · full profile →Form 4 · filed May 8, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$463K
Net Open-Market Flow
-$463K
Transactions
4
3 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 6, 2026Option exercise(M)4K$22.86$94K213K
May 6, 2026Sell(S)4K$83.92$311K209K
May 6, 2026Sell(S)2K$84.60$152K207K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 6, 2026Option exercise(M)4K—$0123K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-26-058129) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML